ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

NURO NeuroMetrix Inc

4.55
0.08 (1.79%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
NeuroMetrix Inc NURO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.08 1.79% 4.55 13:00:07
始値 安値 高値 終値 前日終値
4.45 4.28 4.45 4.30 4.47
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1921:00GLOBENeuroMetrix Announces Steps Taken to Enhance Shareholder..
2024/3/1422:00GLOBENeuroMetrix Announces Publication of Study Demonstrating..
2024/3/1322:00GLOBENeuroMetrix announces that over 2000 patients with..
2024/3/0707:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0707:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0707:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0707:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:12EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/3/0207:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2806:45EDGAR2Form 8-K/A - Current report: [Amend]
2024/2/2806:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/2/2707:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/2/2221:15EDGAR2Form 8-K - Current report
2024/2/2221:00GLOBENeuroMetrix Reports Q4 and Full Year 2023 Business..
2024/2/2104:49EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
2024/2/1523:00GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
2024/2/1323:00GLOBENeuroMetrix Announces Review of Strategic Options to Promote..
2023/12/1223:00GLOBENeuroMetrix Reports Encouraging Results from Pilot Clinical..
2023/12/0523:00GLOBENeuroMetrix Announces Peer-Reviewed Publication of Phase 2..
2023/11/2023:33EDGAR2Form 8-K - Current report
2023/11/2023:00GLOBENeuroMetrix Announces One-for-Eight Reverse Stock Split
2023/10/2705:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/2620:11EDGAR2Form 8-K - Current report
2023/10/2620:00GLOBENeuroMetrix Reports Q3 2023 Business Highlights
2023/10/2400:13GLOBENeuroMetrix, Inc. Announces Date for Third Quarter 2023..
2023/10/2103:59EDGAR2Form 8-K - Current report
2023/10/0222:00GLOBENeuroMetrix and the National Fibromyalgia Association to..
2023/9/1120:59EDGAR2Form DEF 14A - Other definitive proxy statements
2023/8/1206:11EDGAR2Form 8-K - Current report
2023/8/0507:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0507:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0507:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0506:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2805:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/7/2805:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2720:24EDGAR2Form 8-K - Current report
2023/7/2720:00GLOBENeuroMetrix Reports Q2 2023 Business Highlights
2023/7/2102:00GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2023..
2023/7/1122:00GLOBENeuroMetrix Announces Sales Force Expansion for Quell..
2023/6/2822:00GLOBERecent Publications Demonstrate Utility of DPNCheck® for..
2023/6/0722:00GLOBEDiabetic Peripheral Neuropathy Screening That Includes..
2023/5/3122:00GLOBEQuell® Demonstrates Encouraging Clinical Trial Results in..

最近閲覧した銘柄

Delayed Upgrade Clock